Resihance contains Regorafenib 40 mg, a targeted therapy used to treat metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and liver cancer. It works by blocking proteins that help cancer cells grow and spread.
| Generic Name | Regorafenib |
| Manufacturer | Bayer Zydus Pharma |
| Packing | 28 Tablets |
| Prescribed For | Metastatic colorectal cancer, gastrointestinal stromal tumors, and liver cancer |
| Expiry | December 2027 |
Regonat contains Regorafenib 40 mg, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Expiry | December 2027 |
Stivarga 40 mg Tablet contains Regorafenib, an oral targeted therapy used to treat certain types of cancers such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Bayer |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Metastatic Colorectal Cancer, GIST, and Hepatocellular Carcinoma |
| Expiry | December 2027 |
